BEUDAMED
    FDA Adverse Event Injury Summary report: N

    THERMOCOOL SMARTTOUCH SF

    MDR report key: 22501353 · Received July 14, 2025

    Report

    Report Number
    2029046-2025-02316
    Event Type
    Injury
    Date Received
    July 14, 2025
    Date of Event
    June 19, 2025
    Report Date
    August 13, 2025
    Manufacturer
    BIOSENSE WEBSTER INC
    Product Code
    LPB
    UDI-DI
    10846835010145
    PMA / PMN Number
    P030031
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    JA
    Reporter Occupation
    OTHER
    Health Professional
    N

    Narratives

    Additional Manufacturer Narrative · 0

    AN ANALYSIS OF THE PRODUCT COULD NOT BE PERFORMED SINCE A PHYSICAL SAMPLE WAS NOT RECEIVED FOR EVALUATION. A MANUFACTURING RECORD EVALUATION WAS PERFORMED FOR THE FINISHED DEVICE LOT NUMBER 31431561L AND NO INTERNAL ACTION RELATED TO THE COMPLAINT WAS FOUND DURING THE REVIEW. AS PART OF OUR COMPANY QUALITY SYSTEM PROCESS, ALL DEVICES ARE MANUFACTURED, INSPECTED, AND DISTRIBUTED TO APPROVED SPECIFICATIONS. HOWEVER, IF THE PRODUCT IS RECEIVED AT A LATER DATE, THE INVESTIGATION WILL BE UPDATED AS APPLICABLE. THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY BIOSENSE WEBSTER, INC., OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, BIOSENSE WEBSTER, INC., OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE. MANUFACTURER'S REFERENCE NUMBER: (B)(4).

    Additional Manufacturer Narrative · 0

    DURING AN INTERNAL REVIEW ON 17-JUL-2025, NOTED A CORRECTION TO THE 3500A INITIAL, UNDER THE D4. PRIMARY UDI NUMBER AS IT SHOULD HAVE BEEN PROCESSED AS (B)(4), THEREFORE, CORRECTED. ADDITIONAL INFORMATION WAS RECEIVED ON 22-JUL-2025. THE PHYSICIAN¿S OPINION ON THE CAUSE OF THIS ADVERSE EVENT WAS THAT THE PATIENT HAD DIFFICULTY IN ANATOMY AT THE TIME OF THE CTI ABLATION. THEN, THE PHYSICIAN HAD A LITTLE SENSATION SUGGESTIVE OF CARDIAC TAMPONADE. THE INTERVENTION PROVIDED WAS NOREPINEPHRINE WAS ADMINISTERED, AND DRAINAGE WAS PERFORMED. THE PATIENT DID NOT REQUIRE EXTENDED HOSPITALIZATION. THE PROCEDURAL ACT WAS AROUND 350 SECONDS. ONE TIME CATHETER EXCHANGE OCCURRED DURING THE PROCEDURE. ONE TRANSSEPTAL PUNCTURE SITE WAS PERFORMED DURING THE PROCEDURE. THE DELIVERED ENERGY DELIVERED WAS RF. NO EVIDENCE OF STEAM POP. THE FLOW SETTING FOR IRRIGATED CATHETER WAS 2 ML AND 15ML DURING ABLATION. THE CORRECT CATHETER SETTINGS WERE SELECTED ON THE GENERATOR. NO ISSUES WITH FLOW RATE CHANGE AT THE START OF ABLATION. THE FORCE VISUALIZATION FEATURES USED WERE VECTOR. THE VISITAG MODULE PARAMETERS FOR STABILITY USED WAS RANGE: 3MM, TIME: 2SEC, FOT: 25%3G, AND TAG SIZE: 2MM. NO ADDITIONAL FILTER WAS USED WITH THE VISITAG. THE COLOR OPTIONS USED PROSPECTIVELY WAS TAG INDEX. THE SETTINGS FOR POWER AND TIME USED WAS 40W AND 999 SECONDS. IN ADDITION, PROVIDED CONCOMITANT PRODUCTS. THEREFORE, UPDATED THE D 10. CONCOMITANT MEDICAL PRODUCTS AND THERAPY DATES SECTION. IF ADDITIONAL INFORMATION IS RECEIVED REGARDING THIS EVENT, A SUPPLEMENTAL 3500A REPORT WILL BE SUBMITTED TO THE FDA. MANUFACTURER'S REFERENCE NUMBER: (B)(4).

    Description of Event or Problem · 0

    IT WAS REPORTED AFTER CARDIAC ABLATION PROCEDURE WITH A THERMOCOOL SMARTTOUCH SF CATHETER, THE PATIENT EXPERIENCED DECREASE VITAL SIGNS/CARDIAC TAMPONADE TREATED WITH NOREPINEPHRINE AND DRAINAGE. AFTER THE PROCEDURE, A DECREASE IN BLOOD PRESSURE/CARDIAC TAMPONADE WAS OBSERVED AND THEREFORE ECHOCARDIOGRAPHY WAS PERFORMED. NOREPINEPHRINE WAS ADMINISTERED, WHICH LED TO AN INCREASE IN BLOOD PRESSURE. DRAINAGE WAS THEN PERFORMED. NO EXTENDED HOSPITALIZATION. NO ABNORMALITIES OBSERVED PRIOR/DURING USE OF THE PRODUCT. ADDITIONAL INFORMATION WAS RECEIVED. THE OUTCOME OF THE ADVERSE EVENT WAS IMPROVED. THE ENERGY SOURCE USED WHEN THE ADVERSE EVENT OCCURRED WAS RADIO FREQUENCY (RF). PRIOR TO NOTING THE CARDIAC TAMPONADE, ABLATION WAS PERFORMED. NO PFA ENERGY SOURCE WAS USED. THE PATIENT DID NOT REQUIRE CARDIAC SURGERY. NO ERROR MESSAGES OBSERVED ON BIOSENSE WEBSTER EQUIPMENT DURING THE PROCEDURE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    396038 THERMOCOOL SMARTTOUCH SF CARDIAC ABLATION PERCUTANEOUS CATHETER LPB BIOSENSE WEBSTER INC 31431561L 10846835010145

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Female Life Threatening| R